The difference in the expression of the five ADME genes (SLC16A1, SLC7A5, SLCO1B1, CYP17A1, and ABCC8) between tumor and normal tissues was significant and was closely correlated with the survival of patients with NSCLC (Figure 5). This evidence concerns the gene SLCO1B1 and neoplasm.